NBIX

Neurocrine Biosciences
D

NBIX

143.930
USD
0.25
(0.17%)
مغلق
حجم التداول
28,390
الربح لكل سهم
6
العائد الربحي
-
P/E
43
حجم السوق
14,275,194,734
أصول ذات صلة الأخبار المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.